XTX Topco Ltd Purchases New Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC)

XTX Topco Ltd purchased a new position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 26,408 shares of the company’s stock, valued at approximately $26,000. XTX Topco Ltd owned approximately 0.09% of NeuroOne Medical Technologies as of its most recent filing with the Securities & Exchange Commission.

NeuroOne Medical Technologies Stock Up 0.0 %

Shares of NASDAQ NMTC opened at $0.76 on Monday. The stock has a market capitalization of $23.38 million, a P/E ratio of -1.58 and a beta of 0.54. The stock’s 50 day moving average price is $0.81 and its two-hundred day moving average price is $0.83. NeuroOne Medical Technologies Co. has a 52-week low of $0.55 and a 52-week high of $1.72.

NeuroOne Medical Technologies (NASDAQ:NMTC) last announced its quarterly earnings data on Tuesday, December 17th. The company reported ($0.11) earnings per share (EPS) for the quarter. NeuroOne Medical Technologies had a negative return on equity of 276.12% and a negative net margin of 308.51%.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.